Cargando…
Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model
BACKGROUND: Fuzheng Yiliu decoction (FZYLD), a Chinese formula consisting of four herbs, can be clinically used as an adjuvant therapy after surgery or palliative treatment for advanced liver cancer. METHODS: This study identified the endogenous and exogenous metabolites of FZYLD in rat serum to cha...
Autores principales: | Zhang, Hongcheng, Dai, Qiwen, Zeng, Maogui, Liu, Yingying, Du, Jian, Pang, Wensheng, Hu, Juan, Chen, Liwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492441/ https://www.ncbi.nlm.nih.gov/pubmed/36160035 http://dx.doi.org/10.2147/CMAR.S377621 |
Ejemplares similares
-
Fuzheng Yiliu Formula Regulates Tumor Invasion and Metastasis through Inhibition of WAVE3 Expression
por: Chen, Wen-li, et al.
Publicado: (2021) -
Antitumor effect of IL-12 gene-modified bone marrow mesenchymal stem cells combined with Fuzheng Yiliu decoction in an in vivo glioma nude mouse model
por: Wu, Jianjun, et al.
Publicado: (2021) -
Network Pharmacology Interpretation of Fuzheng–Jiedu Decoction against Colorectal Cancer
por: Shi, Hongshuo, et al.
Publicado: (2021) -
Traditional Chinese medicine, Fuzheng Kang-Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway
por: Li, Longmei, et al.
Publicado: (2017) -
Traditional Chinese medicine, Fuzheng Kang-Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway
por: Li, Longmei, et al.
Publicado: (2021)